INTERNATIONAL PATENT: FIBRALIGN CORPORATION FILES APPLICATION FOR "METHOD AND DEVICE FOR MODULATING LYMPHATIC PATHWAY OF CENTRAL NERVOUS SYSTEM"

GENEVA, Jan. 20 -- FIBRALIGN CORPORATION (32930 Alvarado-Niles RoadSuite 350Union City, California 94587) filed a patent application (PCT/US2025/036874) for "METHOD AND DEVICE FOR MODULATING LYMPHATIC PATHWAY OF CENTRAL NERVOUS SYSTEM" on Jul 08, 2025. With publication no. WO/2026/015577, the details related to the patent application was published on Jan 15, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PAUKSHTO, Michael V. (820 Peary LaneFoster City, California 94404)

Abstract: In some embodiments herein, implantable scaffolds, their compositions, and methods for modulating lymphatic pat...